Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to characterize the dose-response of CP-690-550 over the range of 1-15 mg BID on ACR-20 response criteria at 12 weeks.
Inclusion criteria
- Rheumatoid Arthritis